LONDON (Reuters) – Could Pfizer acquire GlaxoSmithKline as a "plan B" after failing to land AstraZeneca ? It would be a stretch but not totally impossible, according to analysts at Berenberg Bank.

from Reuters: Deals http://ift.tt/1xKwvAe
via IFTTT

Publicités